A clinical trial indicates that orforglipron, an oral GLP-1 drug, is as effective as injectable drugs in lowering blood sugar and aiding weight loss for Type 2 diabetes. Its pill form offers greater convenience and potential for wider use compared to injectable alternatives. Further trials are underway for weight loss in non-diabetics.
